1. Paeonol pharmacokinetics in the rat following i.m. administration

   • Li-Yan Ma
   • Xu-Dong Xu
   • Bing-Lan Tang

   OriginalPaper Pages: 133 - 136

2. The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes

   • Momir Mikov
   • Hani Al-Salami
   • J. Paul Fawcett

   OriginalPaper Pages: 137 - 142

3. The pharmacokinetics of JS-38, a novel antineoplastic drug, in rats

   • Hong Zhang
   • Yu Fang
   • Quan-Hai Liu

   OriginalPaper Pages: 143 - 148

4. The effect of molecular weight on the biodistribution of hyaluronic acid radiolabeled with¹¹¹In after intravenous administration to rats

   • E. Svanovsky
   • V. Velebny
   • M. Laznicek

   OriginalPaper Pages: 149 - 157

5. Effects of verapamil on etoposide pharmacokinetics after intravenous and oral administration in rats

   • Yong-Ji Piao
   • Xiuguo Li
   • Jun-Shik Choi

   OriginalPaper Pages: 159 - 164

6. The influence of lamivudine, stavudine and nevirapine on the pharmacokinetics of chlorpropamide in human subjects

   • M. T. Bakare-Odunola
   • I. Enemali
   • K. B. Mustapha

   OriginalPaper Pages: 165 - 171

7. Anticoagulant-induced changes on antibiotic concentrations in the serum and bones

   • A. Kotsiou
   • E. Diamanti
   • C. Tesseromatis

   OriginalPaper Pages: 173 - 179

8. Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals

   • N. Duborija-kovacevic
   • V. Jakovljevic
   • Z. Tomic

   OriginalPaper Pages: 181 - 186

9. Allometric prediction of the human pharmacokinetic parameters for naveglitazar

   • Preeti Ahlawat
   • Nuggehally R. Srinivas

   OriginalPaper Pages: 187 - 190

10. Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies

    • Yasunori Nakagawa
    • Yoko Ichii
    • Kenshi Suzuki

    OriginalPaper Pages: 191 - 198